Intellia Therapeutics: A Look Back At 2019 And Forward To 2020

About: Intellia Therapeutics, Inc. (NTLA)
by: Dan Strack
This article is exclusive for subscribers.
Dan Strack
Long only, value, contrarian, dividend growth investing

Intellia made significant advancements throughout 2019.

The company's partnership with Novartis remains uncertain.

2020 could see wild fluctuations in the stock price.

As 2019 comes to a close, it's important to look back and examine what went right and what went wrong in your portfolio, as well as how your stocks are situated to perform in the